Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Plus Grants Program

University of Toronto

$12,500.00

Development of an essential component for a low cost, high resolution selenium based x-ray imaging system for Western and emerging markets

FY 2016-17

Summary
It is estimated that worldwide approximately 1.7 million women are diagnosed with breast cancer per year.Mammography is the gold standard for detection of this disease. In countries where breast cancer screeningwith mammography is not commonly practised, cancers are more frequently detected when they are already atan advanced stage and prognosis is poor. XLV Diagnostics Inc. was created to develop a low costmammography system to expand the reach of mammography screening. XLV's technology will be especiallyattractive in emerging markets, such as China, India and Brazil, where breast cancer cases are outpacing accessto image based diagnostic technology, as well as in low resources areas within Canada. This low cost highresolution technology may also prove useful in future radiologic applications such as extremity imaging andbone fracture assessment.XLV digital technology, conceived by Canadian scientists, offers a substantial decrease in cost over traditionalflat panel mammography detectors by eliminating the need for large area transistor arrays and expensive, highdensity, low noise electronics. Instead a thin liquid crystal layer is positioned between an amorphous seleniumlayer and an optical scanner based on consumer electronics technology. In addition to XLV supplying completedigital mammography systems, it will also be possible to upgrade existing analogue screen-film units to digitalby replacing the screen-film assembly with modular XLV digital sensors. XLV will be working withSunnybrook Research Institute to develop a means to accelerate charge erasure in their selenium based liquidcrystal mammography system, a key limitation in the current design. This will allow high quality mammogramsto be acquired with increased patient throughput. Ultimately, the successful development of this noveltechnology can then be applied to the development of other low cost, high resolution, digital x-ray systems.
Program
Engage Plus Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
507012-2016
Name nom
Whyne, Cari
Department département
Surgery
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3302
Research subject group en
Condensed matterphysics
Research subject group fr
Physique de la matière condensée
Research subject en
Electronic properties of solids
Research subject fr
Propriétés électroniques des solides
Partie
1
Nb partie
1
Application title
Development of an essential component for a low cost, high resolution selenium based x-ray imaging system for Western and emerging markets
Keyword
NSERC
Application summary
It is estimated that worldwide approximately 1.7 million women are diagnosed with breast cancer per year.Mammography is the gold standard for detection of this disease. In countries where breast cancer screeningwith mammography is not commonly practised, cancers are more frequently detected when they are already atan advanced stage and prognosis is poor. XLV Diagnostics Inc. was created to develop a low costmammography system to expand the reach of mammography screening. XLV's technology will be especiallyattractive in emerging markets, such as China, India and Brazil, where breast cancer cases are outpacing accessto image based diagnostic technology, as well as in low resources areas within Canada. This low cost highresolution technology may also prove useful in future radiologic applications such as extremity imaging andbone fracture assessment.XLV digital technology, conceived by Canadian scientists, offers a substantial decrease in cost over traditionalflat panel mammography detectors by eliminating the need for large area transistor arrays and expensive, highdensity, low noise electronics. Instead a thin liquid crystal layer is positioned between an amorphous seleniumlayer and an optical scanner based on consumer electronics technology. In addition to XLV supplying completedigital mammography systems, it will also be possible to upgrade existing analogue screen-film units to digitalby replacing the screen-film assembly with modular XLV digital sensors. XLV will be working withSunnybrook Research Institute to develop a means to accelerate charge erasure in their selenium based liquidcrystal mammography system, a key limitation in the current design. This will allow high quality mammogramsto be acquired with increased patient throughput. Ultimately, the successful development of this noveltechnology can then be applied to the development of other low cost, high resolution, digital x-ray systems.